BHBrisa Guadalupe Hernández-Ramírez

Brisa Guadalupe Hernández-Ramírez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Brisa Guadalupe Hernández-Ramírez has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Positional Isomerism Influences pH-Responsive Release Kinetics in Methacryloyloxybenzoic Acid Polymeric Prodrugs

    by Hebrón Vázquez-Estudillo, Giovanni Palomino-Vizcaino, Brisa G. Hernández-Ramírez, Lilia A. Hurtado-Ayala, Jonathan Vincent Lopez-Baena, Teresa G. Rodriguez-Tellez, Iván Cordova-Guerrero, Lucia E. Azuara-Alvarez, Arturo Estolano-Cobián, Kenia Palomino-Vizcaino, et al.

    Polymeric prodrugs capable of pH-responsive drug release are promising platforms for localized and controlled drug delivery. While positional isomerism is known to affect the physicochemical properties of MBA polymers, a comparative evaluation of its effect on drug release kinetics and biological activity is lacking. In this study, three methacryloyloxybenzoic acid (MBA) polymeric prodrugs derived from ortho-, meta-, and para-hydroxybenzoic acid (HBA) isomers were synthesized to comparatively evaluate the influence of substituent position on HBA release profiles and biological performance. The o-, m-, and p-MBA monomers and their corresponding polymers were synthesized and structurally characterized by FTIR-ATR, 1H-NMR and UV-Vis spectroscopy. HBA release profiles investigated under physiologically relevant pH conditions revealed markedly distinct release profiles among the polymers. Poly(o-MBA) exhibited rapid and near-complete release at intestinal and physiological pH, poly(p-MBA) showed sustained and intermediate release, and poly(m-MBA) displayed minimal release under all tested conditions, indicating that substituent position strongly influences HBA release, likely through differences in ester accessibility and hydrolytic susceptibility. The polymers also exhibited planktonic antibacterial activity against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa, while BALB/3T3 fibroblast viability remained above 70% at a concentration of 0.5 mg/mL. These findings indicate that positional isomerism is a key structural determinant of pH-responsive release kinetics in MBA polymers and highlight their potential as versatile platforms for pharmaceutical and biomedical applications, particularly in the design of localized and controlled drug delivery systems.

  • Open Access

    Dual-Action Sutures: Chlorhexidine and Dexamethasone for Infection Control and Inflammation Suppression

    by Brisa Guadalupe Hernández-Ramírez, Giovanni Palomino-Vizcaino, Lilia Angélica Hurtado-Ayala, Jonathan Vincent Lopez-Baena, Hebrón Vazquez-Estudillo, Arturo Estolano-Cobián, Teresa G. Rodriguez-Tellez, Héctor Milla-Hinojosa, José Manuel Cornejo-Bravo, Kenia Palomino-Vizcaino, et al.

    Surgical site infections (SSIs) remain a major clinical challenge, particularly due to bacterial adhesion and biofilm formation on suture materials. In this study, we developed a dual drug-eluting suture incorporating chlorhexidine (CHX) and dexamethasone (DEX), with lauric acid used as a binding agent to enhance drug adhesion. The exact composition of the system was CHX/DEX/Lauric Acid, designed to enable localized delivery of both therapeutic agents at the implantation site. Vicryl sutures were dip-coated and characterized by means of FTIR-ATR and HPLC to confirm drug incorporation and release. Mechanical integrity was preserved, with no significant difference in tensile strength between coated and uncoated sutures. Antimicrobial activity was confirmed against Gram-positive and -negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), in addition to the yeast Candida albicans. Cell viability assays demonstrated acceptable biocompatibility, with values exceeding 70%. These findings support the potential of dual-functionalized sutures to reduce SSIs and modulate inflammation, offering a promising strategy for improving postoperative outcomes.